Pay in 4 interest-free payments of $5.81 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The first weekend on 0.25 mg was the worst
Commercial Insurance Trends Mounjaro for diabetes: Generally well-covered by most plans Zepbound for weight loss: Coverage improving but many exclusions remain Both medications: Increasing employer GLP-1 coverage (25%+ expected for 2026) Note: CVS Caremark dropped Zepbound coverage starting mid-2025
An Overview of Tirzepatide Tirzepatide is sold mainly under the brand names Zepbound and Mounjaro
References: Kommu, S
Semaglutidea medication originally designed for type 2 diabetes that is now making headlines for its remarkable effectiveness in weight loss
Wegovy is specifically approved for chronic weight management in adults with obesity or overweight and at least one weight-related health issue
US$ 22.98
US$ 25.15
US$ 21.07
US$ 21.91
US$ 20.24
